2014
DOI: 10.1038/cddis.2014.124
|View full text |Cite
|
Sign up to set email alerts
|

Arginine vasopressin neuronal loss results from autophagy-associated cell death in a mouse model for familial neurohypophysial diabetes insipidus

Abstract: Familial neurohypophysial diabetes insipidus (FNDI) characterized by progressive polyuria is mostly caused by mutations in the gene encoding neurophysin II (NPII), which is the carrier protein of the antidiuretic hormone, arginine vasopressin (AVP). Although accumulation of mutant NPII in the endoplasmic reticulum (ER) could be toxic for AVP neurons, the precise mechanisms of cell death of AVP neurons, reported in autopsy studies, remain unclear. Here, we subjected FNDI model mice to intermittent water depriva… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

3
36
0

Year Published

2015
2015
2021
2021

Publication Types

Select...
5
3

Relationship

0
8

Authors

Journals

citations
Cited by 45 publications
(39 citation statements)
references
References 51 publications
(64 reference statements)
3
36
0
Order By: Relevance
“…The majority of congenital neurogenic (central) diabetes insipidus cases occur as an autosomal-dominant disease, whereby any one of dozens of mutations in the AVP gene (e.g., G57S or ΔE47) cause ER retention of proAVP and the formation of fibrillar aggregates (2,(5)(6)(7)(8). Recent studies have shown that activation of autophagy and autophagy-associated neuronal death occur in response to proAVP aggregation at later stages of diabetes insipidus in mouse models subjected to intermittent water deprivation (9); however, the molecular mechanisms underlying physiological and pathophysiological proAVP folding and degradation remain to be explored. While both WT and mutant proAVP are subjected to proteasomal degradation (10), the nature and mechanisms of the degradative machinery (and, more importantly, the significance of this process in normal physiology and disease initiation) are totally unknown.…”
Section: Introductionmentioning
confidence: 99%
“…The majority of congenital neurogenic (central) diabetes insipidus cases occur as an autosomal-dominant disease, whereby any one of dozens of mutations in the AVP gene (e.g., G57S or ΔE47) cause ER retention of proAVP and the formation of fibrillar aggregates (2,(5)(6)(7)(8). Recent studies have shown that activation of autophagy and autophagy-associated neuronal death occur in response to proAVP aggregation at later stages of diabetes insipidus in mouse models subjected to intermittent water deprivation (9); however, the molecular mechanisms underlying physiological and pathophysiological proAVP folding and degradation remain to be explored. While both WT and mutant proAVP are subjected to proteasomal degradation (10), the nature and mechanisms of the degradative machinery (and, more importantly, the significance of this process in normal physiology and disease initiation) are totally unknown.…”
Section: Introductionmentioning
confidence: 99%
“…31) The analyses of animal models for FNDI have demonstrated that accumulation of mutant AVP precursors in the endoplasmic reticulum (ER) causes ER stress and dysfunction of the neurons, which finally lead to loss of AVP neurons. [31][32][33] This is consistent with autopsy studies which showed that magnocellular neurons were lost in patients with FNDI. 34) TREATMENT Desmopressin, an analogue of AVP, is used for the treatment of CDI.…”
Section: Pathophysiologysupporting
confidence: 79%
“…[31][32][33] This is consistent with autopsy studies which showed that magnocellular neurons were lost in patients with FNDI. 34) TREATMENT Desmopressin, an analogue of AVP, is used for the treatment of CDI.…”
Section: Pathophysiologysupporting
confidence: 79%